Neurophet to Participate in RSNA 2024: Unveiling Multiple Sclerosis Analysis Technology with Neurophet AQUA
- Written by PR Newswire
![]() |
- Demonstrates MS Analysis Technology, Recently Secured FDA 510(k) Clearance
- Introduces 'Neurophet AQUA AD,' a Total Solution for Alzheimer's Disease Treatment Prescription, at the AI Theater
SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in...















